Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Change-In-Working-Capital" stands at 1.53 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.93 Billion Swiss Francs compared to the value the year prior.
The 1 year change is 2.93 Billion Swiss Francs.
The 3 year change is 1.96 Billion Swiss Francs.
The 5 year change is 2.47 Billion Swiss Francs.
The 10 year change is 2.65 Billion Swiss Francs.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change In Working Capital | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change In Working Capital | 486,508,953,600.00 |
![]() | AbbVie Inc - Change In Working Capital | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Change In Working Capital | 280,205,508,085.11 |
![]() | Novartis AG - Change In Working Capital | 255,096,620,580.91 |